Human Chimeric Antibodies

BBI’s Humanised Chimeric Antibodies

BBI’s humanised antibodies are reproducible and highly characterised preparations with defined purity at concentrations suitable for use as a critical raw material in rare autoimmune diseases.

Immunoassays for the detection of antibodies in patient samples and serological methods require reference materials to determine cut-off values and test assay integrity, and these are then included in the kit as calibrators and positive controls. One of the latest advances in assay development is the use of chimeric antibodies as an alternative to characterised disease state plasma which is limited in availability, shows variability and also has safety and ethical issues. BBI has developed a range of specific chimeric antibodies for these applications where disease state plasma is difficult to source.

Connective Tissue Diseases

Product Name Code Type Applications
PCNA humAb 36601 Antibodies ELISA, Lineblot Buy now
PCNA humAb 36600 Antibodies ELISA, Lineblot Buy now
Jo-1 humAb 37301 Antibodies ELISA, Lineblot Buy now
Jo-1 humAb 37300 Antibodies ELISA, Lineblot Buy now
PL-7 humAb 36801 Antibodies ELISA, Lineblot Buy now
PL-7 humAb 36800 Antibodies ELISA, Lineblot Buy now
PL-12 humAb 36901 Antibodies ELISA, Lineblot Buy now
PL-12 humAb 36900 Antibodies ELISA, Lineblot Buy now
SRP54 humAb 36501 Antibodies ELISA, Lineblot Buy now
SRP54 humAb 36500 Antibodies ELISA, Lineblot Buy now
Mi-2 humAb 36700 Antibodies ELISA, Lineblot Buy now
Mi-2 humAb 36701 Antibodies ELISA, Lineblot Buy now

Autoimmune Liver Diseases

Product Name Code Type Applications
LKM1 humAb 36401 Antibodies ELISA, Lineblot Buy now
LKM1 humAb 36400 Antibodies ELISA, Lineblot Buy now
LC1 humAb 37101 Antibodies ELISA, Lineblot Buy now
LC1 humAb 37100 Antibodies ELISA, Lineblot Buy now
SLA/LP humAb 36201 Antibodies ELISA, Lineblot Buy now
SLA/LP humAb 36200 Antibodies ELISA, Lineblot Buy now
PDC-E2 humAb 37201 Antibodies ELISA, Lineblot Buy now
PDC-E2 humAb 37200 Antibodies ELISA, Lineblot Buy now
Sp100 humAb 37001 Antibodies ELISA, Lineblot Buy now
Sp100 humAb 37000 Antibodies ELISA, Lineblot Buy now

Brochure

Products & Services

Inside this catalog you’ll find one of the industry’s broadest collections of enzymes, antibodies, antigens, and more – meticulously developed to power world-class diagnostics and keep your pipeline moving.

Download

Brochure

Reagents Range

Discover our collection of reagents covering a comprehensive range of biomarkers and applications for the IVD market, life sciences, cell culture and beyond.

Download

How do I store and transport the material?

Serums and plasmas should be stored below -15°C and the use of dry ice is recommended for shipping. Repeated freeze-thaw cycles should be avoided as this can cause the material to become “cloudy” due to residual Fibrinolysis.

Where do BBI collect the serum and plasma?

BBI’s Serum and plasma is collected at hospitals and blood banks worldwide, specific sources can be used if requested however bespoke collections can take additional time to facilitate. Most pooled normal human serum and plasma and depleted serum are from US sourced paid blood donations.

How are the units screened for infectious disease markers?

Most of our products are screened for the current World Health Organisation (WHO) list of recognised infectious agents (https://www.who.int/bloodsafety/ScreeningDonatedBloodforTransfusion.pdf) and the results are listed on the product C of A, however as they are derived from human materials they should be treated as potentially hazardous and only handled in laboratories with appropriate biological containment facilities. Some Disease State Plasma products may be positive for specific infectious agents which will be reported on the product Certificate of Analysis. These materials should be handled in laboratories with appropriate biological containment facilities.

How can I get further information about the product?

Technical information and product specifications can be found in the product-specific Certificate of Analysis and the Product Information Sheet. If any further technical information is required, this can be requested by emailing technicalsupport@bbisolutions.com or contacting customer services.

What range of Serum and plasma products are available from BBI, what are they generally used for?

BBI supplies the following human serum and plasma products:

  • Pooled normal human serum and plasma for use as calibrator/control bases and product testing
  • Pooled specific disease state plasma used for calibrators/controls for immunology products
  • Analyte depleted serum and plasma used as negative base for calibrators/controls

What is the difference between serum and plasma?

Plasma and serum are both the liquid portion of blood that remains once the cells are removed.

Plasma is the liquid that is formed when the cellular components are removed, and clotting is prevented with the addition of an anticoagulant. There may be residual anticoagulant remaining in the plasma.

Serum is the liquid that remains after the blood has been allowed to clot, then the cellular components are removed. It does not contain fibrinogens as these are removed as part of the blood clot. The resulting serum will not contain any anticoagulant.

What volumes of serum and plasma products are available?

Typical volumes depend on the specific product however in general individual unit volumes for Disease state plasma range between 1ml samples and up to 1L however generally these are available as 200- 240ml remnants and 850-950ml units with samples of 1-5ml. Depleted serums and pooled normal human serums are available in lots of up to 50L.

Are the Disease state plasma serum and plasma products sourced by BBI from plasmapheresis or are they “remnant” materials collected from blood transfusion and other procedures?

Disease state serums and plasmas are collected as remnants and as plasmapheresis units, the availability is specific to the analyte. Please contact your account manager or customer service for details.

How are the analyte levels determined in BBI serum and plasma products?

Specific immunoassays are normally used to determine the levels of the analytes. These are specified on the Certificate of Analysis. In some cases it is possible to offer an alternative method to those stated, please contact your account manager for details. In certain cases, the materials are tested by LC-MS (Liquid chromatography mass spectroscopy).

Are samples available from all serum and plasma prior to purchase?

Plasma and serum samples can normally be provided; however to ensure that the product is likely to meet the requirement it is essential to agree the titre requirement and testing methodology, as well as any other specifications, prior to sampling. Units of the bulk can be held for a maximum of 3 months pending sample approval.

Request a sample

How are humanised antibodies produced?

Human chimeric monoclonal antibodies are produced in transgenic mouse strains in which the sequence for mouse IgG1 fc region is substituted with the human sequence. After mouse immunisation and the use of hybridoma technology, antibodies are generated that retain a human constant region for recognition by the anti-human conjugate.

Autoantibodies against intracellular antigens are commonly found in connective tissue disorders. One example is SLE which can involve joints, kidneys, skin, mucous membranes and blood vessel walls. The idiopathic inflammatory myopathies dermatomyositis (DM) and polymyositis (PM) are characterised by the presence of inflammatory infiltrates within the skeletal muscle.

Autoantibodies to tRNA synthetases are closely linked with AM/PM detection and diagnosis. Autoantibodies against PL-7 and PL-12 have been found in up to 6% of myositis patients. Anti SRP autoantibodies are mainly associated with a syndrome of a necrotising myopathy and severe prognosis. Autoantibodies against MI-2 are considered specific serological markers of DM. Detected in about 20% of myositis sera they are proven markers for acute onset and good response to therapy. Autoantibodies against PCNA are detected in about 5-10% of SLE patients.

Antibodies graphic

Are you developing an In Vitro assay?

BBI now offers these specificities for IVD manufacturers developing in vitro assays that require a consistent, reliable source of raw material positive calibrator and quality control materials. Materials are stored and shipped from our Freiburg facilities. From this facility our materials are prepared and supplied directly to clients in Europe and non-China Asian territories. For customers in America and China, our Freiburg products are distributed through our carefully selected and highly reputable partners.

Contact Us

BBI's Capabilities

Specialists

Worldwide-Graphic

We have extensive experience in sourcing raw materials worldwide

Salt/solvent fractionation

Growth-Graphic

Batch sizes of up to 5,000 litres

Chromatography

Checklist-Graphic

Ion exchange chromatography, affinity chromatography, size exclusion chromatography, hydrophobic interaction chromatography

Crystallisation

Stars-Graphic

Highly effective protein purification using solvent and aqueous media

Ultrafiltration

Check-Graphic

Volumes of 2,500 - 30,000 litres

Freeze drying

Temperature-Graphic

Capability of 49 - 420 litres per cycle

Quality control

Diamond-Graphic

In-process analysis and monitoring, development of assay/test procedures

Product handling/sampling

Arrows-Graphic

We offer special packing according to customer specifications

SIGN-UP

Keep in touch

Put performance data, early reagent releases, and news & offers in your inbox. Join us in advancing health, together.

This field is for validation purposes and should be left unchanged.